.

Amarin reported $94.44M in Sales Revenues for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
DBV Technologies DBVT:US 1.53M 1.02M
Abbvie ABBV:US $ 14583M 1045M
Aerie Pharmaceuticals AERI:US $ 33.31M 3.48M
Alnylam Pharmaceuticals ALNY:US $ 224.82M 11.56M
Amarin AMRN:US $ 94.44M 0.19M
AstraZeneca AZN:LN 884686.86M 17406.7M
Biocryst Pharmaceuticals BCRX:US $ 65.53M 15.61M
Epizyme EPZM:US $ 27.53M 18.83M
Esperion Therapeutics ESPR:US $ 18.84M 5K
GlaxoSmithKline GSK:LN 692900M 26100M
Halozyme Therapeutics HALO:US $ 152.36M 35.09M
Heron Therapeutics HRTX:US $ 27.63M 4.17M
Intercept Pharmaceuticals ICPT:US $ 71.76M 16.82M
IONIS PHARMACEUT IONS:US $ 133.79M 8.13M
JAZZ PHA JAZZ:US $ 932.88M 119.16M
Nektar Therapeutics NKTR:US $ 21.58M 3.24M
Neurocrine Biosciences NBIX:US $ 378.2M 67.6M
Novartis NOVN:VX SF 13085M 271M
Teva Pharmaceutical Industries TEVA:US $ 3786M 125M